Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection

Lancet

Volumn 351, Issue 9118, 1998, Pages 1773-1777

  Shibata, Minoru ^a   Morizane, Toshio ^b   Uchida, Toshikazu ^c   Yamagami, Tomoyuki ^a   Onozuka, Yasushi ^a   Nakano, Masayuki ^d   Mitamura, Keiji ^e   Ueno, Yukihisa ^a  

^a Kawasaki Cooperation Hospital   (Japan)

^b KANAGAWA DENTAL COLLEGE   (Japan)

^c NIHON UNIVERSITY   (Japan)

^d CHIBA UNIVERSITY   (Japan)

^e SHOWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; CELL REGENERATION; CHRONIC HEPATITIS; ECHOGRAPHY; FOLLOW UP; GENDER; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTE COUNT;

EID: 0032513884     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)08002-1     Document Type: Article

References (25)

1. 1 Zanman SN, Melia W, Johnson RD, Portmann BC, Johnson PJ, Williams R. Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients. Lancet 1985; ii: 1357-60.
2. 2 Mohamed AE, Kew MC, Groeneveld HT. Alcohol consumption as a risk factor for hepatocellular carcinoma in urban southern African blacks. Int J Cancer 1992; 51: 537-41.
3. 3 Hadengue A, N'Dri N, Benhamou JP. Relative risk of hepatocellular carcinoma in HBsAg positive vs alcoholic cirrhosis: a cross-sectional study. Liver 1990; 10: 147-51.
4. 4 Nalpas B, Driss F, Pol S, et al. Association between HCV and HBV infection in hepatocellular carcinoma and alcoholic liver disease. J Hepatol 1991; 12: 70-72.
5. 5 Bruix J, Barrera JM, Calvet X, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and chronic hepatitis. Lancet 1989; ii: 1004-08.
6. 6 Simonetti RG, Camma C, Fiorello F, et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis: a case-control study. Ann Intern Med 1992; 116: 97-102.
7. 7 Borzio M, Bruno S, Roncalli M, et al. Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study. Gastroenterology 1995; 108: 812-17.
8. 8 Ganne-Carie N, Chastang C, Chapel F, et al. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in western patients with cirrhosis. Hepatology 1996; 23: 1112-18.
9. 9 De Mitri MS, Poussin K, Baccarini P, et al. HCV-associated liver cancer without cirrhosis. Lancet 1995; 345: 413-15.
10. 10 Takano S, Yokosuka O, Imazeki F, Tagawa M, Omata M. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology 1995; 21: 650-55.
11. 11 Uchida T. Small hepatocellular carcinoma: its relationship to multistep hepatocarcinogenesis. Pathol Int 1995; 45: 175-84.
12. 12 Peters RL. Viral inflammatory disease. In: Peters RL, Craig JR, eds. Liver pathology contemporary issues in surgical pathology. New York: Churchill Livingstone, 1986: 73-123.
13. 13 Uchida T. Pathology of hepatitis C. Intervirology 1994; 37: 126-32.
14. 14 Uchida T, Koronborg I, Peters RL. Acute viral hepatitis: morphologic and functional correlations in human livers. Hum Pathol 1984; 15: 267-77.
15. 15 Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-99.
16. 16 Anthony PP, Vogel CL, Barker LF. Liver cell dysplasia: a premalignant condition. J Clin Pathol 1973; 26: 217-23.
17. 17 Lefkowitch JH, Arborgh BAM, Sheuer PJ. Oxyphilic granular hepatocytes: mitochondria-rich liver cells in hepatic disease. Am J Clin Pathol 1980; 74: 432-41.
18. 18 Gibson JB, Sobin LH. Histological typing of tumors of the liver, biliary tract and pancreas. International histological classification of tumors no 20. Geneva: WHO, 1978: 12-30.
19. 19 Landis RJ, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-74.
20. 20 Hoofnagle JH, Di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997; 336: 347-56.
21. 21 Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-35.
22. 22 Kato Y, Nakata K, Omagari K, et al. Risk of hepatocellular carcinoma in patients with cirrhosis in Japan: analysis of infectious hepatitis viruses. Cancer 1994; 74: 2234-38.
23. 23 Kuwana K, Ichida T, Kamimura T, et al. Risk factors and the effect of interferon therapy in the development of hepatocellular carcinoma: a multivariate analysis in 343 patients. J Gastroenterol Hepatol 1997; 12: 149-55.
24. 24 Tozuka S, Uchida T, Suzuki K, Esumi M, Shikata T. State of hepatitis B virus DNA in hepatocytes of patients with noncarcinomatous liver disease: its special relationship with necroinflammatory activity and the stage of disease. Arch Pathol Lab Med 1989; 113: 20-25.
25. 25 Henmi A, Uchida T, Shikata T. Karyometric analysis of liver cell dysplasia and hepatocellular carcinoma: evidence against precancerous nature of liver cell dysplasia. Cancer 1985; 55: 2594-99.